查看購物車
  • Simplified Chinese
  • English
2021-2031年亞太地區抗生素和抗真菌藥物市場報告：範圍、細分、動態和競爭分析
市場調查報告書
商品編碼
1871449

2021-2031年亞太地區抗生素和抗真菌藥物市場報告：範圍、細分、動態和競爭分析

Asia Pacific Antibiotics & Antimycotics Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 191 Pages | 訂單完成後即時交付

價格

預計亞太地區抗生素和抗真菌藥物市場將顯著成長，到 2031 年將達到約 405.4575 億美元，高於 2023 年的 265.7038 億美元，反映出 2023 年至 2031 年預測期內的年複合成長率為 5.4%。

執行摘要和市場分析

該市場分為幾個主要區域，包括中國、日本、印度、韓國、澳洲以及亞太其他地區。推動該市場成長的主要因素是該地區細菌和真菌感染（例如肺炎、泌尿道感染、性傳染病和皮膚感染）發病率的上升。此外，市場參與者的策略性舉措，包括新產品的推出和核准，預計將在未來幾年為市場擴張創造豐厚的機會。

市場區隔

亞太地區抗生素和抗真菌藥物市場可以透過多種細分市場進行分析，包括藥物類別、適應症、給藥途徑和配銷通路：

  • 藥物類別：市場將藥物分為多個類別，包括青黴素類、頭孢菌素類、碳青黴烯類、大環內酯類、氨基糖苷類、喹諾酮類、磺胺類、四環素類、唑類等。 2023年，頭孢菌素類佔據最大的市場佔有率。
  • 適應症：市場根據適應症進行細分，例如皮膚感染、呼吸道感染、泌尿道感染、敗血症、耳部感染、胃腸道感染等。 2023年，皮膚感染佔最大市場佔有率。
  • 給藥途徑：市場分為口服、外用和其他給藥途徑，其中口服給藥在 2023 年最為常見。
  • 配銷通路：分銷管道包括醫院藥房、零售藥房和線上藥房，其中醫院藥房在 2023 年佔據市場佔有率領先地位。

市場展望

人們對真菌感染及其健康影響的認知不斷提高，加之政府和私營部門的積極舉措，是推動抗生素和抗真菌藥物市場成長的重要因素。全球真菌感染行動基金（GAFFI）報告稱，全球有超過3億人患有嚴重的真菌疾病，每年導致約150萬人死亡，超過瘧疾和結核病死亡人數的總和。如此驚人的盛行率促使人們加強教育和診斷工作，提高醫護人員和病患對及時治療必要性的認知。

分子檢測等診斷方法的創新提高了真菌病原體的早期檢出率，進一步增加了對有效抗真菌治療的需求。全球真菌病防治聯合會（GAFFI）於2015年制定的「消除真菌疾病十年路線圖」概述了有效診斷的關鍵條件。包括國際人類和動物真菌學會（ISHAM）和歐洲疾病預防控制中心（ECDC）在內的多個組織正積極致力於提高公眾對真菌感染負擔的認知，並推廣預防、診斷和治療策略。每年9月16日至20日舉行的「真菌疾病宣傳週」旨在提高公眾對真菌疾病日益普遍以及採取適當應對措施必要性的認知。

國家概況

亞太地區抗生素和抗真菌藥物市場按國家/地區進行了進一步分析，其中中國在2023年佔據最大的市場佔有率。中國真菌和細菌感染（例如泌尿道感染和肺炎）的發生率不斷上升，這推動了對抗生素和抗真菌藥物的需求。根據《流行病學與感染雜誌》2023年的數據，中國每年約有2,110萬人感染社區型肺炎（CAP）。中國常用的抗生素包括青黴素類、氟喹諾酮類、頭孢菌素類和硝基咪唑類。

市場參與者的策略性舉措，包括產品發布和研發，預計將創造顯著的成長機會。例如，2024年9月，廣州中以生物產業投資基金2期有限責任合夥企業向BioVersys投資600萬美元，用於支持其靶向耐碳青黴烯類鮑曼不動桿菌的藥物BV100在中國開展臨床試驗。 2023年3月，珠峰醫藥（Everest Medicines）的藥物Xerava（依拉環素）獲得中國國家藥品監督管理局的新藥申請批准，用於治療成人複雜性腹腔內感染。

公司簡介

抗生素和抗真菌藥物市場的主要參與者包括輝瑞公司、諾華公司、賽諾菲公司、羅氏公司、默克公司、葛蘭素史克公司、強生公司、西普拉公司、拜耳公司、艾伯維公司和安斯泰來製藥公司。這些公司正在採用各種策略，例如擴張、產品創新以及併購，以增強其市場佔有率並為消費者提供創新解決方案。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：

第4章：亞太地區抗生素和抗真菌藥物市場－主要市場動態

  • 市場促進因素
    • 傳染病發生率不斷上升
    • 人們對真菌感染的認知不斷提高
  • 市場限制
    • 抗菌素抗藥性、經濟障礙和繁瑣的監管程序
  • 市場機遇
    • 持續的資金投入與研發計劃
  • 未來趨勢
    • 產品開發和治療輸送方法的技術進步
  • 駕駛員和安全帶的影響：

第5章：抗生素和抗真菌藥物市場—亞太地區分析

  • 2021-2031年亞太地區抗生素及抗黴菌藥物市場收入
  • 亞太地區抗生素和抗真菌藥物市場預測分析

第6章：亞太地區抗生素與抗黴菌藥物市場分析－依藥物類別分類

  • 青黴素
  • 頭孢菌素
  • 碳青黴烯類
  • 大環內酯類
  • 氨基糖苷類
  • 奎諾酮類
  • 磺胺類藥物
  • 四環素類
  • 唑類
  • 其他

第7章：亞太地區抗生素和抗真菌藥物市場分析－依適應症分類

  • 皮膚感染
  • 呼吸道感染
  • 泌尿道感染（UTI）
  • 敗血症
  • 耳部感染
  • 胃腸道感染
  • 其他

第8章：亞太地區抗生素和抗真菌藥物市場分析－按給藥途徑分類

  • 口服
  • 主題
  • 其他

第9章：亞太地區抗生素和抗真菌藥物市場分析－按配銷通路分類

  • 醫院藥房
  • 零售藥局
  • 網路藥局

第10章：亞太地區抗生素與抗黴菌藥物市場－國別分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區

第11章：抗生素和抗真菌藥物市場——產業概況

  • 概述
  • 抗生素和抗真菌藥物市場成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第12章：公司簡介

  • Pfizer Inc
  • Novartis AG
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd
  • Merck & Co Inc
  • GSK Plc
  • Johnson & Johnson
  • Cipla Ltd
  • Bayer AG
  • AbbVie Inc
  • Astellas Pharma Inc

第13章：附錄

Product Code: BMIRE00032106

The Asia Pacific antibiotics and antimycotics market is projected to grow significantly, reaching approximately US$ 40,545.75 million by 2031, up from US$ 26,570.38 million in 2023, reflecting a compound annual growth rate (CAGR) of 5.4% during the forecast period from 2023 to 2031.

Executive Summary and Market Analysis

The market is divided into several key regions, including China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of this market is primarily driven by the rising incidence of bacterial and fungal infections, such as pneumonia, urinary tract infections (UTIs), sexually transmitted diseases, and skin infections across the region. Additionally, strategic initiatives by market players, including new product launches and approvals, are expected to create lucrative opportunities for market expansion in the coming years.

Market Segmentation

The Asia Pacific antibiotics and antimycotics market can be analyzed through various segments, including drug class, indication, route of administration, and distribution channel:

  • Drug Class: The market is categorized into several drug classes, including penicillin, cephalosporins, carbapenems, macrolides, aminoglycosides, quinolones, sulfonamides, tetracyclines, azoles, and others. In 2023, cephalosporins held the largest market share.
  • Indication: The market is segmented based on indications such as skin infections, respiratory infections, UTIs, septicemia, ear infections, gastrointestinal infections, and others. Skin infections accounted for the largest share in 2023.
  • Route of Administration: The market is divided into oral, topical, and other routes of administration, with oral administration being the most prevalent in 2023.
  • Distribution Channel: The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with hospital pharmacies leading the market share in 2023.

Market Outlook

The increasing awareness of fungal infections and their health implications, along with initiatives from both government and private sectors, are significant factors contributing to the growth of the antibiotics and antimycotics market. The Global Action Fund for Fungal Infections (GAFFI) reported that over 300 million people globally suffer from serious fungal diseases, leading to approximately 1.5 million deaths annually, surpassing the combined fatalities from malaria and tuberculosis. This alarming prevalence has prompted enhanced educational efforts and diagnostic initiatives, raising awareness among healthcare providers and patients about the critical need for timely treatment.

Innovations in diagnostic methods, such as molecular testing, have improved the early detection of fungal pathogens, further increasing the demand for effective antifungal treatments. GAFFI's 10-year roadmap for eliminating fungal diseases, established in 2015, outlines essential conditions for effective diagnostic delivery. Various organizations, including the International Society for Human and Animal Mycology (ISHAM) and the European Centre for Disease Prevention and Control (ECDC), are actively working to highlight the burden of fungal infections, promoting prevention, diagnosis, and treatment strategies. The annual Fungal Disease Awareness Week, observed from September 16-20, aims to raise awareness about the growing prevalence of fungal diseases and the need for appropriate responses.

Country Insights

The Asia Pacific antibiotics and antimycotics market is further analyzed by country, with China holding the largest market share in 2023. The country is witnessing a rising prevalence of fungal and bacterial infections, such as UTIs and pneumonia, which drives the demand for antibiotics and antimycotics. According to the Epidemiology and Infection Journal 2023, around 21.1 million individuals in China are affected by community-acquired pneumonia (CAP) annually. Commonly used antibiotics in China include penicillins, fluoroquinolones, cephalosporins, and nitroimidazoles.

Strategic initiatives by market players, including product launches and developments, are expected to create significant growth opportunities. For example, in September 2024, Guangzhou Sino-Israel Bio-Industry Investment Fund 2 LLP invested US$ 6.0 million in BioVersys to support clinical trials in China for BV100, targeting carbapenem-resistant Acinetobacter baumannii. In March 2023, Everest Medicines received a New Drug Application from China's National Medical Products Administration for Xerava (eravacycline) to treat complex intra-abdominal infections in adults.

Company Profiles

Key players in the antibiotics and antimycotics market include Pfizer Inc., Novartis AG, Sanofi SA, F. Hoffmann-La Roche Ltd, Merck & Co Inc., GSK Plc, Johnson & Johnson, Cipla Ltd, Bayer AG, AbbVie Inc., and Astellas Pharma Inc. These companies are employing various strategies, such as expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Infectious Diseases
    • 4.1.2 Growing Awareness About Fungal Infections
  • 4.2 Market Restraints
    • 4.2.1 Antimicrobial Resistance, Financial Barriers, and Extensive Regulatory Processes
  • 4.3 Market Opportunities
    • 4.3.1 Ongoing Funding and Research & Development Initiatives
  • 4.4 Future Trends
    • 4.4.1 Technological Advancements in Product Development and Treatment Delivery Approaches
  • 4.5 Impact of Drivers and Restraints:

5. Antibiotics and Antimycotics Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Antibiotics and Antimycotics Market Forecast Analysis

6. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Drug Class

  • 6.1 Penicillin
    • 6.1.1 Overview
    • 6.1.2 Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Cephalosporines
    • 6.2.1 Overview
    • 6.2.2 Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Carbapenems
    • 6.3.1 Overview
    • 6.3.2 Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Macrolides
    • 6.4.1 Overview
    • 6.4.2 Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Aminoglycosides
    • 6.5.1 Overview
    • 6.5.2 Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Quinolones
    • 6.6.1 Overview
    • 6.6.2 Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 Sulfonamides
    • 6.7.1 Overview
    • 6.7.2 Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Tetracyclines
    • 6.8.1 Overview
    • 6.8.2 Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.9 Azoles
    • 6.9.1 Overview
    • 6.9.2 Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.10 Others
    • 6.10.1 Overview
    • 6.10.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Indication

  • 7.1 Skin Infections
    • 7.1.1 Overview
    • 7.1.2 Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Respiratory Infections
    • 7.2.1 Overview
    • 7.2.2 Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Urinary Tract Infections (UTI)
    • 7.3.1 Overview
    • 7.3.2 Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Septicemia
    • 7.4.1 Overview
    • 7.4.2 Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Ear Infections
    • 7.5.1 Overview
    • 7.5.2 Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Gastrointestinal Infections
    • 7.6.1 Overview
    • 7.6.2 Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Topical
    • 8.2.1 Overview
    • 8.2.2 Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Overview
    • 9.1.2 Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Online Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Antibiotics and Antimycotics Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Antibiotics and Antimycotics Market Overview
    • 10.1.2 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.1 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
      • 10.1.2.2 China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.2.1 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.2.2 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.2.3 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.2.4 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.3 Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.3.1 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.3.2 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.3.3 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.3.4 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.4 India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.4.1 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.4.2 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.4.3 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.4.4 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.5 Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.5.1 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.5.2 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.5.3 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.5.4 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.6 South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.6.1 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.6.2 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.6.3 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.6.4 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
      • 10.1.2.7 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.2.7.1 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
        • 10.1.2.7.2 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
        • 10.1.2.7.3 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
        • 10.1.2.7.4 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

11. Antibiotics and Antimycotics Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Antibiotics and Antimycotics Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Pfizer Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Novartis AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sanofi SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 F. Hoffmann-La Roche Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Merck & Co Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 GSK Plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Johnson & Johnson
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Cipla Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Bayer AG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 AbbVie Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Astellas Pharma Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation
  • Table 2. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Drug Class
  • Table 4. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Indication
  • Table 5. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Route of Administration
  • Table 6. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Distribution Channel
  • Table 7. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 8. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 9. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 10. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 11. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 12. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 13. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 14. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 15. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 16. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 17. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 18. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 19. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 20. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 21. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 22. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 23. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 24. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 25. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 26. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 27. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 28. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
  • Table 29. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
  • Table 30. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
  • Table 31. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 32. Recent Organic Growth Strategies in Antibiotics and Antimycotics Market
  • Table 33. Recent Inorganic Growth Strategies in the Antibiotics and Antimycotics Market
  • Table 34. Glossary of Terms, Antibiotics and Antimycotics Market

List Of Figures

  • Figure 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation - Country
  • Figure 2. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Drug Class (2023 and 2031)
  • Figure 6. Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Indication (2023 and 2031)
  • Figure 17. Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Route of Administration (2023 and 2031)
  • Figure 25. Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Distribution Channel (2023 and 2031)
  • Figure 29. Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Asia Pacific Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 34. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 35. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 36. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 39. Growth Strategies in Antibiotics and Antimycotics Market